Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
29.3M
-
Shares change
-
+462K
-
Total reported value, excl. options
-
$1.08B
-
Value change
-
+$20.4M
-
Put/Call ratio
-
0.71
-
Number of buys
-
92
-
Number of sells
-
-58
-
Price
-
$36.83
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q2 2020
192 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q2 2020.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.3M shares
of 51.1M outstanding shares and own 57.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.55M shares), VANGUARD GROUP INC (3.45M shares), STATE STREET CORP (2.25M shares), Redmile Group, LLC (2.24M shares), JPMORGAN CHASE & CO (1.92M shares), DIMENSIONAL FUND ADVISORS LP (702K shares), GOLDMAN SACHS GROUP INC (601K shares), Aquilo Capital Management, LLC (553K shares), CREDIT SUISSE AG/ (537K shares), and GEODE CAPITAL MANAGEMENT, LLC (511K shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.